Topiramate Capsule
Product Images NDC 24979-211

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 24979-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure of the active ingredient Topiramate, showing its molecular configuration with labeled oxygen, sulfur, nitrogen, carbon, and hydrogen atoms forming the compound.*

FDA Label Image

Figure1 (Figure 1)

A Kaplan-Meier plot showing cumulative rates for time to first seizure over 500 days comparing Topamax 50 mg/day (solid line) with Topamax 400 mg/day (dashed line). The graph includes sample sizes for each group and a reported p-value (0.0002). The y-axis represents cumulative seizure rates, and the x-axis represents time in days.*

FDA Label Image

Figure2 (Figure 2)

This bar chart compares the change from baseline to double-blind phase in average monthly migraine period rate for placebo and Topamax doses (50 mg/day, 100 mg/day, 200 mg/day) across two studies (Study 11 and Study 12). The vertical axis shows change in migraine rate, with Topamax doses demonstrating greater reductions than placebo, especially at 100 mg/day and 200 mg/day doses, with significant p-values indicated.*

FDA Label Image

Image Description (Usl 15)

Topiramate Capsules, USP 15 mg in a carton label showing the dosage form as capsules and the package count of 60 capsules. The label displays directions for dispensing, storage instructions, and manufacturer information, indicating Upsher-Smith Laboratories, LLC as the labeler. The label includes warnings and capsule description details.*

FDA Label Image

Image Description (Usl 25)

Topiramate Capsules, USP 25 mg oral capsules by Upsher-Smith Laboratories, LLC. The label indicates the package contains 60 capsules with white to off-white spherical coated pellets inside a white opaque capsule marked '25 mg' and 'TWi 1211'. Storage instructions and distributor details are included along with a pharmacist dispensing note.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.